Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure - activity relationships in 1,4-benzodiazepines

P A Borea

    Bollettino Della Societa Italiana Di Biologia Sperimentale
    |March 30, 1981
    PubMed
    Summary

    This study quantitatively correlates benzodiazepine activity against pentylenetetrazole using the Hansch model. Lipophilicity and electron-withdrawing substituents significantly influence anticonvulsant effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A(2A) adenosine receptors and Parkinson's disease severity.

    Acta neurologica Scandinavica·2013
    Same author

    Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts.

    Journal of cellular physiology·2011
    Same author

    Allosteric enhancers of A1 adenosine receptors: state of the art and new horizons for drug development.

    Current medicinal chemistry·2010
    Same author

    Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes.

    British journal of pharmacology·2010
    Same author

    A3 adenosine receptor: pharmacology and role in disease.

    Handbook of experimental pharmacology·2009
    Same author

    Adenosine receptors and cancer.

    Handbook of experimental pharmacology·2009

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology
    • Quantitative Structure-Activity Relationship (QSAR) studies

    Background:

    • Benzodiazepines are a class of psychoactive drugs known for their anxiolytic, sedative, hypnotic, and anticonvulsant properties.
    • Pentylenetetrazole (PTZ) is a convulsant drug used to induce seizures in animal models for studying anticonvulsant activity.
    • Quantitative Structure-Activity Relationship (QSAR) studies aim to correlate the biological activity of chemical compounds with their physicochemical properties.

    Purpose of the Study:

    • To quantitatively correlate the antipentylenetetrazole activity of 35 benzodiazepine derivatives.
    • To identify key physicochemical parameters that govern the anticonvulsant effects of these benzodiazepines.
    • To apply the Hansch model for predicting drug activity based on molecular properties.

    Main Methods:

    • Utilized the Hansch model, a QSAR approach, to analyze a series of 35 benzodiazepine compounds.
    • Correlated antipentylenetetrazole (PTZ) activity with various physicochemical parameters of the benzodiazepine substituents.
    • Focused on parameters such as overall lipophilicity and electronic properties of substituents at specific positions.

    Main Results:

    • A quantitative correlation was established between benzodiazepine antipentylenetetrazole activity and their physicochemical parameters.
    • Overall lipophilicity of the benzodiazepine molecules was found to be a significant factor influencing activity.
    • The presence of highly electron-withdrawing substituents at positions 7 and 2' of the benzodiazepine structure was strongly correlated with enhanced activity.

    Conclusions:

    • Benzodiazepine anticonvulsant activity against pentylenetetrazole can be quantitatively predicted using physicochemical properties.
    • Lipophilicity and specific electronic characteristics of substituents are critical determinants of antipentylenetetrazole efficacy.
    • The findings provide valuable insights for the rational design of novel benzodiazepine-based anticonvulsant agents.

    Related Experiment Videos